Back to Search Start Over

Keeping It “Current”: A Review of Treatment Options for the Management of Supraventricular Tachycardia

Keeping It “Current”: A Review of Treatment Options for the Management of Supraventricular Tachycardia

Authors :
Tednes, Patrick
Marquardt, Samantha
Kuhrau, Shannon
Heagler, Kristin
Rech, Megan
Source :
The Annals of Pharmacotherapy; 20240101, Issue: Preprints
Publication Year :
2024

Abstract

Objective: To review treatment options and updates that exist for the management of paroxysmal supraventricular tachycardia (PSVT).Data Sources: A literature search of PubMed was performed including articles from 1974 to June 2023 using the terms: arrhythmias, adenosine, verapamil, diltiazem, esmolol, propranolol, metoprolol, beta-blockers, amiodarone, PSVT, synchronized cardioversion, methylxanthines, dipyridamole, pediatrics, heart transplant, and pregnancy. Primary literature and guidelines were reviewed.Study Selection and Data Extraction: Studies were considered if they were available in English and conducted in humans.Data Synthesis: PSVT is a subset of supraventricular tachycardia (SVT) that presents as a rapid, regular tachycardia with an abrupt onset and termination. Due to frequent emergency department (ED) visits annually with symptoms of PSVT, appropriate and efficient management of these patients is vital. This review provides an overview of the pathophysiology of PSVT, while also describing the literature behind nonpharmacologic and pharmacologic management of PSVT.Relevance to Patient Care and Clinical Practice: This review describes new literature regarding the improved success of the modified Valsalva maneuver as a nonpharmacologic therapy in PSVT. In addition, it describes a new technique in administration of adenosine that has improved outcomes, defines dose adjustments needed for drug interactions with adenosine, compares the utilization of nondihydropyridine calcium channel blockers with adenosine, and provides management recommendations for patients in special populations.Conclusions: With high annual rates of ED visits for SVT, providers should be aware of the data behind management and modifications of therapy based on patient-specific factors (ie, patient preference, pharmacokinetics/pharmacodynamics, drug interactions, and special populations).

Details

Language :
English
ISSN :
10600280 and 15426270
Issue :
Preprints
Database :
Supplemental Index
Journal :
The Annals of Pharmacotherapy
Publication Type :
Periodical
Accession number :
ejs65885737
Full Text :
https://doi.org/10.1177/10600280231199136